A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

A research group led by Wei Li at the Chinese Academy of Sciences has created mice born from two male parents and capable of ...

Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Drs Emmanuelle Charpentier and Jennifer Doudna have won this year’s Nobel Prize for chemistry in recognition of their work on the gene-editing technology CRISPR/Cas9. Charpentier – currently ...

The UK has approximately 17,500 individuals living with sickle cell disease, a condition particularly prevalent amongst those ...

NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...

Casgevy, also known as exa-cel, was the first treatment to be licensed using gene-editing tool Crispr, which earned its inventors the Nobel Prize for chemistry in 2020. It works by editing the fau ...

NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...

A revolutionary gene therapy treatment costing a staggering £1.65 million has been approved for NHS use, offering patients ...

The UK is poised to lead the next great leap in agriculture, with gene-editing technology offering a lifeline to a ...

A £1.65 million treatment has been approved for use for some NHS patients, offering hope of a cure to those with an inherited ...